§721.1907. Butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis N -2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo-.
40 C.F.R. § 721.1907
Chemical substance and significant new uses subject to reporting.
The chemical substance generically identified as butanamide, 2,2′-[3′dichloro[1,1′-biphenyl]-4,4′-diyl)bisazobis N-2,3-dihydro-2-oxo-1H-benximdazol-5-yl)-3-oxo- (PMN P-93-1111) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
The significant new uses are—
Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(iii), and (g)(5). The following additional statements shall appear on each label and Safety Data Sheet (SDS) as specified by this paragraph: This substance decomposes in polymers or sheet metal coatings at temperatures greater than 280 °C to give 3,3′ DCB a suspect human carcinogen.
Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(f) and processing or use at temperatures above 280 °C.
Release to water. Requirements as specified in § 721.90 (b)(1) and (c)(1). When the substance is processed or used as a colorant for dyeing plastics, this section does not apply.
Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.
Recordkeeping. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of this substance.
Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.
Notes, amendments, and revision history
Amendments
[63 FR 5742, Feb. 4, 1998]
Authority
Authority: 15 U.S.C. 2604, 2607, and 2625(c).
Source
Source: 49 FR 35018, Sept. 5, 1984, unless otherwise noted.
Amendments
[63 FR 5742, Feb. 4, 1998]